adminの記事一覧

Clinical utility of tubular markers in kidney disease: a narrative review.

J Lab Precis Med. 2022JLPM

Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation.

Clin Case Rep. 2022doi: 10.1002/ccr3.6531PubMed

Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report.

Open Vet J. 2022doi: 10.5455/OVJ.2022.v12.i6.12 PubMed

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis.

Front Med (Lausanne). 2022PubMed

Effects of dietary phosphorus concentration and phosphate salt form on renal tubule function in unilateral nephrectomized rats .

Nutr Health. 2022PubMed

Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure.

Heart Vessels. 2022doi: 10.1007/s00380-022-02174-0PubMed

The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function .

Physiol Rep. 2022doi: 10.14814/phy2.15420.PubMed

Early biomarkers for kidney injury in heat-related illness patients: a prospective observational study at Japanese Self-Defense Force Fuji Hospital.

Nephrol Dial Transplant. 2022 doi: 10.1093/ndt/gfac166.PubMed

Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study .

Int J Nephrol. 2022PubMed

SGLT2阻害薬の新しい腎保護作用メカニズムを発見　尿細管細胞に炎症を拡大する小胞体タンパクを抑制

■━━━━━━━━━━━━━━━━━━━━━━━━■腎疾患診断用バイオマーカー L-FABP情報サイト■□■□メールマガジン□■□■No.66／2024年5月配信号［医療者向け］https://fabp.jp/?utm_source=mailmagazine&utm_campaign=240